C

Celadon Pharmaceuticals PLC
LSE:CEL

Watchlist Manager
Celadon Pharmaceuticals PLC
LSE:CEL
Watchlist
Price: 13.4 GBX
Market Cap: 9.2m GBX

Intrinsic Value

The intrinsic value of one CEL stock under the Base Case scenario is hidden GBX. Compared to the current market price of 13.4 GBX, Celadon Pharmaceuticals PLC is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CEL Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Celadon Pharmaceuticals PLC

Intrinsic Value History
Dive into the past to invest in the future

CEL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if CEL is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CEL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CEL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Celadon Pharmaceuticals PLC.

Explain Valuation
Compare CEL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CEL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Celadon Pharmaceuticals PLC

Current Assets 1.7B
Cash & Short-Term Investments 1.7B
Other Current Assets 12.4m
Non-Current Assets 296m
PP&E 262.6m
Other Non-Current Assets 33.5m
Current Liabilities 104.4m
Accounts Payable 9.8m
Accrued Liabilities 91.8m
Other Current Liabilities 2.8m
Non-Current Liabilities 214.2m
Other Non-Current Liabilities 214.2m
Efficiency

Free Cash Flow Analysis
Celadon Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Celadon Pharmaceuticals PLC

Revenue
37.4m GBP
Operating Expenses
-383.5m GBP
Operating Income
-346.1m GBP
Other Expenses
-35.8m GBP
Net Income
-381.9m GBP
Fundamental Scores

CEL Profitability Score
Profitability Due Diligence

Celadon Pharmaceuticals PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Celadon Pharmaceuticals PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CEL Solvency Score
Solvency Due Diligence

Celadon Pharmaceuticals PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Celadon Pharmaceuticals PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CEL Price Targets Summary
Celadon Pharmaceuticals PLC

There are no price targets for CEL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Celadon Pharmaceuticals PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for CEL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CEL stock?

The intrinsic value of one CEL stock under the Base Case scenario is hidden GBX.

Is CEL stock undervalued or overvalued?

Compared to the current market price of 13.4 GBX, Celadon Pharmaceuticals PLC is hidden .

Back to Top